David Béchard
Fondateur chez Cytune Pharma SAS
Postes actifs de David Béchard
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Cytune Pharma SAS
 Cytune Pharma SAS Miscellaneous Commercial ServicesCommercial Services Cytune Pharma SAS develops and manufactures immunotherapeutic agents for the treatment of cancer. It offers CYP 0150 produced by recombinant technology adapted to pharmaceutical processes and is the result of a single translation. The company was founded by David Béchard and Yannick Jacques on November 15, 2007 and is headquartered in Nantes, France. | Président | 18/12/2007 | - |
| Fondateur | 15/11/2007 | - | |
| Directeur des opérations | 15/11/2007 | - | |
| President | 15/11/2007 | - |
Historique de carrière de David Béchard
Anciens postes connus de David Béchard
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Atlanpole Biotherapy | Corporate Officer/Principal | - | - |
Endotis Pharma SARL
 Endotis Pharma SARL Pharmaceuticals: MajorHealth Technology Endotis Pharma SARL is a holding company, which is engaged in the development of differentiated cardiovascular therapeutics based on validated targets and modes of action. The company was founded in 2003 and it is headquartered in Romainville, France. | Président | 01/02/2003 | - |
| Fondateur | 01/02/2003 | - | |
| President | 01/02/2003 | - |
Formation de David Béchard
| École des Hautes Études Commerciales de Paris | Graduate Degree |
Statistiques
Internationale
| France | 5 |
Opérationnelle
| Chairman | 2 |
| Founder | 2 |
| President | 2 |
Sectorielle
| Health Technology | 2 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Endotis Pharma SARL
Endotis Pharma SARL Pharmaceuticals: MajorHealth Technology Endotis Pharma SARL is a holding company, which is engaged in the development of differentiated cardiovascular therapeutics based on validated targets and modes of action. The company was founded in 2003 and it is headquartered in Romainville, France. | Health Technology |
Cytune Pharma SAS
Cytune Pharma SAS Miscellaneous Commercial ServicesCommercial Services Cytune Pharma SAS develops and manufactures immunotherapeutic agents for the treatment of cancer. It offers CYP 0150 produced by recombinant technology adapted to pharmaceutical processes and is the result of a single translation. The company was founded by David Béchard and Yannick Jacques on November 15, 2007 and is headquartered in Nantes, France. | Commercial Services |
| Atlanpole Biotherapy |
- Bourse
- Insiders
- David Béchard
- Expérience
